FindTrial
Sign In

The investiaton of comprehenve genetic mutation in patients with HCC and hepatitis.

The investiaton of comprehenve genetic mutation in patients with HCC and hepatitis. - The investiaton of comprehenve genetic mutation in patients with HCC and hepatitis.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024590
Enrollment
50
Registered
2016-10-27
Start date
2016-04-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC/hepatitis

Interventions

We collect DNA from tumor, non-tumor, buffy coat, plasma.

Sponsors

Chiba university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients who conntract HCC or hepatitis

Exclusion criteria

Exclusion criteria: women who are pregnant

Design outcomes

Primary

MeasureTime frame
The genetic mutation of Tumor, Non tumor, buffy coat, plasma in patients with HCC and hepatitis.—

Countries

Japan

Contacts

Public ContactTatsuro Kanda

Chiba university gastroenterology and neohrology

kandat-cib@umin.ac.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026